Inhaled Insulin - ‘Transition’ Programme Put In Place, UK
Dec 29th 2007Drug InformationDiabetes
Following talks with Diabetes UK, Pfizer has announced that it is putting in place an extended ‘transition’ programme to supply Exubera (inhaled insulin) for a up to 12 further months, depending on existing stock levels and expiry dates. [click link for full article]
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
